PHSA - BCC - Bispecific Antibody Education for Nurses

This course will provide BC Cancer nurses the knowledge and skills to safely administer bispecific antibodies.

Bispecific antibodies are a specialized group of hazardous drugs that can elicit dramatic host reactions such as cytokine release syndrome (CRS) and related immune effector cell-associated neurotoxicity syndrome (ICANS) requiring monitoring, prompt recognition, and an advanced level of intervention.


Registered nurses at BC Cancer

1 hour
34349

Contact Information

BC Cancer Professional Practice Nursing

BCCancerPPNAdmin@phsa.ca